Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy
Contributors: World Health Organization; International Agency for Research on Cancer; ebrary, Inc
Series: IARC monographs on the evaluation of carcinogenic risks to humans -- v. 91
Publisher: International Agency for Research on Cancer; Distributed by WHO Press
Published: 2007
Place of publication: Lyon, France; Geneva
Language: eng
Format: [electronic resource]
Number of pages: 528
ISBN-13: 9789283212911
Subjects: Women; Estrogen; Contraception; Catechol estrogens; Hormone therapy; Chemical carcinogenesis; Progestational hormones; Cancer; Menopause; Side effects; Diseases; Carcinogenicity; Complications; Risk factors; Oral contraceptives
Description: This ninety-first volume of IARC Monographs contains evaluations of the carcinogenic hazard to humans of combined estrogen-progestogen contraceptives and combined estrogen-protestogen menopausal therapy. The hormonal drugs reviewed in this volume involve co-administration of an estrogen and a progestogen. Studies that did not provide information on the use of combined estrogen-progestogen agents are not reviewed. It should also be noted that this volume reviews only studies that are publicly available and therefore does not include pharmaceutical test results that are not in the public domain.
Notes: At head of title: World Health Organization, International Agency for Research on Cancer.

"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005."

Includes bibliographical references and cumulative index.

Electronic reproduction. Palo Alto, Calif. : ebrary, 2009. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.